[1]
K. Womperski, “The use of 3,4-Methylenedioxymethamphetamine (MDMA) in the treatment of Post-Traumatic Stress Disorder (PTSD) - review”, J Educ Health Sport, vol. 43, no. 1, pp. 82–92, Aug. 2023.